GW Pharmaceuticals - ADR
NASDAQ:GWPH 11:31:21 AM EDT
| Market Cap (Intraday) | 6.74B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | 457.4 |
| 10-Day MA | $212.43 |
| 50-Day MA | $160.30 |
| 200-Day MA | $126.88 |
GW Pharmaceuticals Plc Stock, NASDAQ:GWPH
Sovereign House, Vision Park, Chivers Way, Cambridge, Cambridgeshire CB24 9BZ
Phone: +44.1223.266800
Number of Employees: 901
Description
GW Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It offers its cannabinoid product, Epidiolex oral solution CV, a pharmaceutical formulation of cannabidiol (CBD) focusing on the treatment of seizures associated with tuberous sclerosis complex. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom.